Scope of Submission
We welcome submissions from a broad range of disciplines, including but not limited to:
- Biologic therapies in rheumatic disease management
- Long-term safety of biologic treatments
- Comparative effectiveness of biologics
- Patient adherence to biologic therapies
- Emerging biologic agents in rheumatology
- Cost-effectiveness of biologic treatments
- Biologics and comorbid conditions management
- Personalized medicine approaches with biologics
- Impact of biologics on disease progression
- Patient education on biologic therapies
- Challenges in access to biologic treatments
- Role of biosimilars in rheumatology
- Clinical trials of new biologic therapies
- Biologics in pediatric rheumatology
- Ethical considerations in biologic research
- Biologic therapy and quality of life
- Innovative delivery methods for biologics
- Impact of biologics on healthcare costs
- Future directions in biologic therapy research
- Collaboration between rheumatologists and researchers
All papers must be original and not previously published or submitted elsewhere.
